Amalgam Rx, a Wilmington, DE-based company which specializes in enabling data-driven health care decision making, received an investment of undisclosed amount from CVS Health Ventures in its Series B round. The company intends to use the funds to expand operations and its business reach. The investment supports the scaling of Amalgam's EHR-integrated clinical decision support [...]The post Amalgam Rx Receives Investment From CVS Health Ventures appeared first on FinSMEs.
Amalgam is a Delaware-based digital health platform that offers solutions such as patient identification and data analysis for healthcare and life sciences industries.